BioJENC aims to research and develop new and/or improved products for better health. Our current focuses are: 1) microbial detection devices, 2) viral vaccines, and 3) brain tumor therapeutics.
Microbial detection devices:
BioJENC's sensitive differential
culture medium can be used to isolate and culture Gram negative and Gram positive bacteria including but not limited
to E. coli, Staphylococcus spp., Streptococcus spp., Pseudomonas spp., Enterobacter spp., Bacillus spp., and others. A rapid and sensitive reagent strip has also been developed to help differentiate
nitrate-reducing bacteria and acid-producing bacteria (results within seconds).
BioJENC provides high quality tests to aid the detection of
microorganisms in biological samples. For student and research laboratories, the tests may also be used for detecting
pH, nitrite, nitrate, and/or nitric oxide metabolites in a sample. Visit our joint poster presentation with the American Red Cross at the 2003 AABB Annual
Meeting for reference of sensitivity. Your orders can be processed by phone (1-225-615-8934) and Fax (1-225-615-8910).
Contact us for more information.
-
For research laboratory tests, our PHIL(TM) differential
culture medium and NiNa(TM) reagent strips provide a sensitive combination for you to detect microorganisms that utilize sugars
and reduce nitrate like E. coli and Staphylococcus aureus.
-
For monitoring dietary nitrate intake, our NiNa(TM) reagent strips provide a sensitive test for you to monitor
if your diet is rich in nitrate. Dietary nitrates may be beneficial to blood flow*.
Viral vaccines: BioJENC targets T-cell specific viral antigens for use as vaccine candidates against influenza and HIV. Our immediate goal in this area is to develop effective vaccines specifically against H5 subtype and seasonal
influenza.
Brain tumor therapeutics: analogs, inhibitors, vaccines
BioJENC has a special interest
in tumors in general, brain tumors in particular. We are particularly interested
in astrocytomas including a relatively new entity named Rosetted Glioneuroma. We
have targeted several areas of interest: epidermal growth factor receptor, tumor protein 53, heparan sulfate proteoglycans,
fibroblast growth factors/receptors, and Fas/FasR.
*
Reference: For more information regarding dietary nitrate, visit www.clinicaltirals.gov/ct/show/NCT00069654.
